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New YorkABSTRACT Adhesion between biological surfaces, which is typically the result of molecular binding between receptors on one
surface and ligands on another, plays a fundamental role in biology and is key to the infection mechanisms of certain viruses,
including influenza. The physiological outcome of adhesion depends on both the number of bound cells (or viruses, or other bio-
logical particles) and the properties of the adhesion interface that is formed, including the equilibrium number of receptor-ligand
connections. Here, we introduce a quantitative model for biological adhesion by adapting thermodynamic models developed for
the related problem of multivalent molecular binding. In our model, adhesion affinity is approximated by a simple, analytical
expression involving the numbers of ligands and receptors at the interface. Our model contains only two fitting parameters and
is simple to interpret. When applied to the adhesion between the hemagglutinin ligands on influenza viruses and the sialic acid
receptors on biosensors or on host cells, our model generates adhesion affinities consistent with experimental measurements
performed over a range of numbers of receptors, and provides a semiquantitative estimate of the affinity range of the hemagglu-
tinin-sialic acid interaction necessary for the influenza virus to successfully infect host cells. Themodel also provides a quantitative
explanation for the experimental finding that amutant avian virus gained transmissibility inmammals despite themutations confer-
ring only a less than twofold increase in the affinity of its hemagglutinin for mammalian receptors: the model predicts an order-of-
magnitude improvement in adhesion to mammalian cells. We also extend our model to describe the competitive inhibition of
adhesion: the model predicts that hemagglutinin inhibitors of relatively modest affinity can dramatically reduce influenza virus
adhesion to host cells, suggesting that such inhibitors, if discovered, may be viable therapeutic agents against influenza.INTRODUCTIONAdhesion between two cells, or between a virus and a cell,
mediates diverse biological phenomena including pathogen
recognition of host cells (1–3), cell trafficking (4–7), and
cell signaling (8,9). Such adhesion typically involves the
simultaneous binding of multiple copies of ligands on one
of the contact surfaces with multiple copies of receptors
on the other (10,11), and at biological interfaces there are
often hundreds to thousands of such ligand-receptor pairs.
Influenza virus, for example, in its first step of infection, at-
taches to vertebrate host cells through the binding between
multiple hemagglutinin (HA) trimers on the viral surface
and multiple copies of the N-acetylneuraminic acid (also
known as sialic acid (SA)) moiety on the host-cell surface
(12). Although the binding between a single pair of HA
and SA molecules is weak (equilibrium dissociation con-
stant KD ~ 1 mM) (13), the large number of HA and SAmol-
ecules present at the contact surface collectively ensures that
the virus adheres to the host cell with high affinity. ThisSubmitted October 24, 2014, and accepted for publication October 29,
2015.
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0006-3495/16/01/0218/16strong adhesion is thus a consequence of multivalent (also
referred to as polyvalent) interactions, where valency refers
to the number of simultaneous connections between one
kind of particle and another.
The physiological outcome of adhesion depends on both
the number of bound cells (or viruses, or other biological
particles) and the properties of the adhesion interface that
is formed, such as the contact surface area, the distance of
cell-cell separation, and the equilibrium number of recep-
tor-ligand connections. Thermodynamic models have been
developed to study the properties of the individual adhesion
interface (14–18). Such models, however, do not calculate
the fraction of bound cells in a given condition (15). Full
characterization of adhesion requires models that can esti-
mate the affinity of adhesion and thus the population of
bound cells, which can now be measured experimentally.
In this study we develop such a model.
Many biological processes involve modulating the
strength of multivalent adhesion, either by changing the
number of available receptors or ligands at the interface or
by changing the binding affinity of each receptor-ligand
pair. Quantitative characterization of such modulation re-
quires a model that accurately estimates the adhesion affin-
ity from the parameters of the underlying receptor-ligand
binding.http://dx.doi.org/10.1016/j.bpj.2015.10.045
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been reported in the literature (11). One widely used
approach approximates the dissociation constant of adhe-
sion, KD,ad, as (KD)
m, where m is referred to as the multiplic-
ity, the value of which depends on the number of adhesive
receptor and ligand molecules at the contact surface (19).
To our knowledge, however, no theoretical model has
been proposed to estimate m from the number of receptors,
NR, the number of ligands, NL, and KD: It can only be
measured empirically at discrete, static numbers of recep-
tors and/or ligands. As suggested above, it is often neces-
sary to consider adhesion for changing numbers of
receptors and ligands and for a range of binding affinities.
The empirical approach is typically difficult to apply in
these problems.
Thermodynamic models have been developed for the
related problem of binding between molecules with multiple
binding sites, such as in multivalent host-guest binding
(20–25). These models relate the avidity of multivalent
binding to the numbers of available binding sites on the
multivalent molecules (receptors and ligands or host and
guest molecules) and to the KD of individual pairs of binding
sites. These models have enjoyed great success treating
molecular systems in which there are <~10 binding site
pairs, but they have not been applied to adhesion between
larger biological particles. Adhesion between larger
particles (e.g., between a virus and a host cell) often
involves a much larger contact interface, which incurs
nonspecific interactions, such as electrostatic repulsion be-
tween membranes, that can significantly affect the adhesion
affinity.
In this work, we extend previous thermodynamic models
of multivalent molecular binding to propose a simple model
of the phenomenon of multivalent adhesion, in part by intro-
ducing a fitting parameter to account for the contribution of
nonspecific interactions. We also introduce approximations
appropriate for the large number of adhesive connections,
resulting in a simple equation that estimates KD,ad from
KD, NR, and NL. Our model establishes a clear relationship
between KD,ad and the equilibrium number of receptor-
ligand connections, the latter being a key quantity in the
groundbreaking model developed by Bell and co-workers
(14–18).
To demonstrate the utility of this approach, we use our
model to study adhesion of influenza virus to SA-conju-
gated biosensors and to host cells. The influenza virus ex-
ploits two mechanisms to modulate its adhesion to host
cells: 1) changing the number of receptors to spread from
cell to cell (26,27), and 2) changing the affinity of recep-
tor-ligand binding to adapt from avian to mammalian hosts
(28–30). We apply our model to the analysis of both mech-
anisms of modulation. Our model accurately reproduces
the experimentally measured relationship between adhe-
sion and the number of available SA molecules conjugated
to biosensors, and quantitatively explains the observedsensitivity of adhesion affinity to small changes in the
HA-SA binding affinity. Our model also provides a quanti-
tative technique for analyzing the functional interplay be-
tween HA-SA binding affinity and the catalytic efficiency
of neuraminidase, and yields a reasonable estimate for
the range of affinity of HA-SA binding that leads to a
viable virus.
We also extend our model to the study of competitive
inhibition of multivalent adhesion. A competitive inhibitor
of the adhesive molecules—against either the receptor or
the ligand—reduces the number of available connection
sites, thus weakening or abolishing adhesion (31). The ef-
ficacy of such an inhibitor depends not only on its affinity
for its molecular target, but also on how the adhesion af-
finity changes with respect to the numbers of available re-
ceptors and ligands. Our model permits a quantitative
analysis of the competitive inhibition of multivalent adhe-
sion. When applied to influenza, our model indicates that
it may be possible to effectively inhibit the adhesion of
influenza virus to host cells using a molecule with only
modest affinity for HA. It might thus be feasible to take
existing modest inhibitors of HA, or discover new ones,
and develop them as therapeutic agents against influenza
infection.MATERIALS AND METHODS
Please see the Supporting Material.RESULTS AND DISCUSSION
Theoretical model
Our model estimates KD,ad of adhesion from the KD of indi-
vidual receptor-ligand binding and the numbers of recep-
tors, NR, and ligands, NL, at the adhesion interface. The
result, which we derive later in this section, is
KD;ad ¼ K0exp

NRln
NR  n
NR
þ NLlnNL  n
NL
þ n

; (1)
where n is the equilibrium number of connections formed
between receptors and ligands, and is obtained from the
equilibrium equation
ðNR  nÞðNL  nÞ
n
¼ KDVeff : (2)
Here, K0 is the 0-valency dissociation constant between the
two surfaces when no connections are formed, and Veff is the
effective molar volume in which receptor-ligand binding oc-
curs. K0 and Veff are difficult to measure directly, but can be
estimated by fitting to adhesion measurements at varying
values of NR and/or NL. Typically, KD can be measured by
standard binding assays or calorimetry, and NR and NL can
be measured by electron microscopy or fluorescence. InBiophysical Journal 110(1) 218–233
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influenza virus, the HA-SA binding affinity has been
measured by nuclear magnetic resonance (13) and micro-
scale thermophoresis (MST) (19), and the number of sialic
acids on the cell surface has been measured by cleavage ex-
periments (32).
We first derive Eq. 1 by the method of statistical me-
chanics, and then give a simple interpretation of the result
at the end. At the adhesion interface, individual connections
between receptors and ligands form and break in a thermo-
dynamic equilibrium, and the number of connections at a
given instant, n, fluctuates between 0 and min (NR, NL).
We assume that the connections form and break indepen-
dently and that the Gibbs free energy change of forming a
connection between a given ligand and receptor is DG ¼
RTln(KDVeff), with R being the gas constant and T the tem-
perature. The molar volume Veff accounts for the adjustment
of the reaction condition, because the binding between the
receptors and the ligands is restrained in the narrow confine
of the adhesive interface, and both the receptors and the li-
gands are tethered to their respective surfaces. Our model in
this form ignores potential cooperativity in receptor-ligand
binding (25), in which the binding free energy of a given re-
ceptor-ligand pair depends on the number of existing con-
nections. Such cooperativity, however, can be included in
our model at the cost of extra parameters, as discussed in
a subsequent section.
At thermal equilibrium, the probability that n connections
are formed is given by
pn ¼ Z1 1
NR!
1
NL!
exp

nDG
RT
 
NR
n
! 
NL
n
!
n!
¼ Z1 exp

nDG
RT

1
ðNR  nÞ!ðNL  nÞ!n!;
(3)
where
Z ¼
XminðNR;NLÞ
n¼ 0 exp

nDG
RT

1
ðNR  nÞ!ðNL  nÞ!n! (4)
is the grand canonical partition function. In the first line of
Eq. 3, the binomials 
NR
n

NL
n

count the numbers of ways to choose n receptors out of a
total NR and n ligands out of a total NL to form n connec-
tions. The value n! stands for the number of ways to pair
the n chosen receptors and ligands. The factor 1/(NR!NL!)
takes into account that the receptors are indistinguishable
from one another and so are the ligands. In situations
where the receptors are attached to fixed locations on a sur-
face (such as experiments in which the receptors are teth-Biophysical Journal 110(1) 218–233ered to a surface through streptavidin-biotin linkers), thus
becoming distinguishable, NR! should be removed from
the denominator. The value pn, however, remains un-
changed. Equation 3 is an extension of the Klotz equation,
first developed for the binding of ligands to receptors with
multiple binding sites (33). The exact number of receptors
and ligands at the contact surface varies among individual
biological particles; in our model we take NR to be the
average number of receptors on receptor-bearing particles,
and NL to be the average number of ligands on ligand-
bearing particles.
The above receptor-ligand binding equilibrium is part of
the overall equilibrium of adhesion between two biological
surfaces C and V,
Cþ V#
K0
CV0#/#CVminðNR;NLÞ; (5)
where CVn stands for the microstate of the adhesion surface
where n connections are formed between the receptors and
the ligands. The 0-valency dissociation constant, K0, ac-
counts for the contribution of nonspecific interactions to
the adhesion affinity.
The dissociation constant of adhesion is thus given by
KD;ad ¼ ½C½V½CV ¼
½C½VXminðNR;NLÞ
n¼ 0 ½CVn
¼ ½C½V½CV0 p0 ¼ K0p0:
(6)
Given KD, NR, NL, K0, and Veff, one can calculate KD,ad from
Eqs. 3, 4, and 6 using a computer program. When NR and NL
are large, however, we can introduce approximations that
greatly simplify the expression of KD,ad and remove the fac-
torials in the equation.
Under conditions where reasonably large numbers of con-
nections form, the grand canonical partition function Z can
be well approximated by the maximum term in the
summand,
Zzexp

 nDG
RT

1
ðNR  nÞ!ðNL  nÞ!n!; (7)
where n is the number at which pn is at its maximum. The
value n thus satisfies pn=pnþ1z1, so
ðNR  nÞðNL  nÞ
n
zexp

DG
RT

¼ KDVeff ; (8)
which implies that n is the equilibrium number of
connections formed between the receptors and the ligands
confined within the adhesion interface. Applying the Stirling
Multivalent Adhesion of Influenza 221approximation ln x! ¼ xlnx – x to lnp0 ¼ ln(ZNR!NL!),
we have
ln p0 ¼  ln Z  ln NR!  ln NL!
z
nDG
RT
þ ðNR  nÞlnðNR  nÞ  ðNR  nÞ
þ ðNL  nÞlnðNL  nÞ  ðNL  nÞ þ nlnn
 n NR ln NR þ NR  NL ln NL þ NL
¼ NR lnNR  n
NR
þ NL lnNL  n
NL
þ n
þ n

DG
RT
 ln ðNR  nÞðNL  nÞ
n

zNR ln
NR  n
NR
þ NL lnNL  n
NL
þ n;
(9)
where the last line is due to Eq. 8. Substituting p0 above in
Eq. 6, we arrive at our expression for KD,ad in Eq. 1.
Equations 1 and 2 can also be derived by considering the
following imaginary thermodynamic process (because the
free energy change of adhesion is the difference between
two state functions and is independent of the connecting
thermodynamic path). The reaction of adhesion can be
approximately decomposed into two steps: 1) the attach-
ment of the two surfaces without the formation of any recep-
tor-ligand connections, and 2) the establishment of the
equilibrium of receptor-ligand binding at the interface.
The total free energy of adhesion is thus
RTlnKD;ad ¼ RTlnK0 þ DGn; (10)
where DGn is the free energy of forming n receptor-ligand
connections, and is given byDGn ¼ nDG RTln

NR
n

NL
n

n!

; (11)
where the second term on the right-hand side is the entropic
contribution due to the number of ways to form n connec-
tions out of NR receptors and NL ligands. Equations 10
and 11, with the Stirling approximation and the same
algebra as in Eq. 9, lead to Eq. 1.
Finally, we derive an approximate expression for the so-
called 0-valency dissociation constant K0, which is valid
when the contribution of nonspecific interactions to this
quantity can be neglected. Suppose that the total numbers
of receptors and ligands exposed on the respective biolog-
ical particles are MR and ML, out of which the NR receptors
and the NL ligands that form the connections are the subsets
that happen to lie within the interface. The value K0 can be
related to the fractions NR/MR and NL/ML, and the effective
molar volume Veff, as follows.
The reaction to form one connection between the two bio-
logical particles is
Cþ V#CV1: (12)If we ignore the nonspecific interactions between the two
biological particles, however, this monovalent reaction is
equivalent to the reaction of individual receptor-ligand bind-
ing, where the receptor and ligand concentrations are MR
andML times the concentrations of the respective biological
particles. As a result, we have
½C½V
½CV1
ð½R=MRÞð½L=MLÞ
½RL ¼
KD
MRML
(13)
and
K0 ¼ ½C½V½CV0 ¼
½C½V
½CV1
½CV1
½CV0 ¼
KD
MRML
p1
p0
¼ NR
MR
NL
ML
V1eff :
(14)
If the fractions NR/MR and NL/ML are known, Veff becomes
the only free parameter in our model. In this work, we treat
K0 as a free fitting parameter, and we check its estimated
value against sensible guesses of the fractions.
We have so far developed the model assuming that one
particle of V adheres to one particle of C. Different types
of biological particles, however, often have disparate sizes.
If C is much larger than V, many particles of V can adhere to
one particle of C, each occupying a nonoverlapping site of
adhesion and making a number of adhesive molecules on
C, which we can call M*, unavailable to other particles of
V. If the total number of adhesive molecules on one particle
of C is M, the number of particles of V adhering to one par-
ticle of C at adhesion equilibrium can be shown to be
v ¼ S
1þ S KD;ad=½V ; (15)
where S ¼ M/M* is the maximum number of particles of V
that can be accommodated on the surface of one particle of
C. Equation 15 is equivalent to the Langmuir equation, S be-
ing the number of sites of adhesion, and K
0
D,ad h SKD,ad
being the per-site dissociation constant of adhesion. Corre-
spondingly, the per-site 0-valency dissociation constant is
K
0
0 ¼ SK0. Clearly, K0D,ad/K00 ¼ KD,ad/K0, and within our
model this ratio still follows from Eq. 1. The value K0 fol-
lows from Eq. 14; note that K
0
0 is also given by Eq. 14 if
we reinterpretMR (orML, if the ligands rather than receptors
lie on C) as the number of adhesive molecules per site of
adhesion (i.e., the number of adhesive molecules on C
made unavailable to other particles of V by adhesion of
one particle of V). Below, we use the more convenient
per-site dissociation constants K
0
0 and K
0
D,ad, but we switch
notation by dropping the prime symbols.
Our model in its simple form (Eqs. 1 and 2) assumes that
only one type of receptor and one type of ligand are present
at the interface, and that the binding affinity between any re-
ceptor-ligand pair is the same. Real cells, however, may pre-
sent diverse sets of different receptor types, each with aBiophysical Journal 110(1) 218–233
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example, may present a range of different glycans that
terminate with the SA moiety, and each type of glycan
may have a different binding affinity for the HA molecule
(34–36). It is straightforward to extend our model to account
for such heterogeneity. If the number of receptors with bind-
ing affinity between K and K þ dK is N(K)dK, the dissoci-
ation constant of adhesion in our model is given by
KD;ad ¼ K0exp
Z
NðKÞlnNðKÞ  nðKÞ
NðKÞ dK
þ NL lnNL  n
NL
þ n

; (16)
where n(K)dK, satisfying the equilibrium equationðNðKÞ  nðKÞÞðNL  nÞ
nðKÞ ¼ KVeff ; (17)
is the equilibrium number of receptor-ligand connectionsAwith binding affinity between K and K þ dK, and
n ¼ !n(K)dK is the total equilibrium number of connections
formed between all receptors and the ligand molecules. The
value n can be determined from the following equation:
n ¼
Z
NðKÞ

1þ KVeff
NL  n
1
dK: (18)
Equations 16–18 (derived in the Supporting Material)
describe a cell’s properties of adhesion once the distribution
of binding affinity N(K) is known for the receptors on the
cell. Equations 1 and 2 are a special case of Eqs. 16–18,
with N(K) ¼ d(K  KD). Our model, thus generalized, can
be used to analyze the variability in adhesion affinity in a
population of cells due to the fluctuations in the expression
levels of different receptors.B
FIGURE 1 The accuracy of our model. (A) The ratio p0/p0,exact as NR is
varied between 1 and 20,000, for different receptor-ligand affinities. The
other model parameters are NL¼ 150, Veff¼ 2.7 103 mM1. (B) The ratio
p0/p0,exact as the concentration of an inhibitor of the ligand is varied. The
parameters NL and Veff have the same values as in (A), and NR ¼ 2000.Properties of the model
The expression of pn and the partition function Z (Eqs. 3 and
4, without the approximations introduced in our model) can
also be derived by equations of mass action, as has been
done in the development of previous models of multivalent
molecular binding (23), if the combinatorial factors of pair-
ing any receptor molecule with any ligand molecule are
properly accounted for. The exact expression of Z (Eq. 4)
can be used as is, but our approximation leads to a simple
analytical expression of the adhesion affinity (Eq. 1), mak-
ing apparent its relationship to the other variables. The
expression in Eq. 1 makes it easy to include NR and NL,
which are discrete variables in the exact solution, as contin-
uous parameters in fitting to experimental adhesion data,
when their values are unknown. It also relates the adhesion
affinity to the equilibrium number of receptor-ligand con-
nections, n, in a simple formula.Biophysical Journal 110(1) 218–233Although Eq. 1 is derived by applying the Stirling approx-
imation at large values of NR, NL, and n, Eq. 1 remains a
good approximation even at small values of these quantities.
Fig. 1 A plots the ratio p0/p0,exact as NR is varied between 1
and 20,000, where p0,exact is given by Eq. 3. In the case of
weak receptor-ligand affinities (KD ~ 1 mM), as in the
case of cell-influenza adhesion, the ratio remains very close
to 1 throughout this range of NR. At stronger affinity, KD ¼
0.001 mM, our model can overestimate the adhesion affinity
by a factor of up to ~2, which may still be acceptable for
most applications.
The strength of adhesion can be modulated by changing
the available number of receptors (or ligands) at the adhe-
sion interface. Consider the adhesion between viruses and
cells: the fraction of bound virus particles is
f ¼ 1
1þ KD;ad=½cell; (19)
where [cell] is the concentration of the cells. The value f
changes with the adhesion affinity, and thus with the number
of receptors NR. Fig. 2 A plots f against NR, holding the num-
ber of ligands, NL, at various fixed values. These adhesion
isotherms are steep at large values of NL. By solving Eq.
19 for NR for any given f, our model can be used to estimate
NR,f, the number of receptors at which that fraction of the vi-
rus particles is bound (Fig. 2 B). At high values of NL, the
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FIGURE 2 Modulation of multivalent adhesion
by changing the number of receptors at the adhe-
sion interface. (A) The fraction of bound virus par-
ticles as a function of the number of receptors at the
adhesion interface. (B) NR,0.5 (solid lines), NR,0.95
(dashed lines above), and NR,0.05 (dashed lines
below) values (see text) as a function of the number
of ligands at the adhesion surface. The gap between
the two dashed lines narrows as NL increases, indi-
cating that at higher valencies it takes a smaller in-
crease in the number of receptors to produce the
same increase in the adhesion affinity. The number
of receptors below which the equilibrium number
of connections becomes no greater than 1
(n % 1) is also shown (dash-and-dot lines). (C)
The equilibrium number of connections, n, when
the fraction of bound virus particles is 0.5 (solid
lines), 0.95 (dashed lines), and 0.05 (dashed lines
below). (D) The probability, p0, of spontaneously
breaking all receptor-ligand connections plotted
against the equilibrium number of connections, n,
at varying numbers of receptors, NR, while the
number of ligands is held constant, at NL ¼ 150.
The black dashed curve corresponds to the limit
p0 ¼ exp(n). Each color of lines (B–D) corre-
sponds to a different receptor-ligand binding affin-
ity KD. The parameters used here are [cell]¼ 4.0
1010 mM, Veff¼ 2.7 103 mM1, andK0¼ 1.0
105 mM; the derivation of these parameter values
is explained in the discussion of cell-influenza
adhesion.
Biophysical Journal 110(1) 218–233
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224 Xu and Shawbound fractions increase quickly from 5 to 95%, with little
change in the number of receptors.
To break apart an adhesion interface, it is not necessary to
reduce the equilibrium number of receptor-ligand connec-
tions to n ¼ 0; when n becomes small enough, thermal fluc-
tuations can spontaneously break all connections—so that
the instantaneous number of connections is 0—which
abolishes the adhesion. Without specific receptor-ligand
connections, cells (and viruses) tend to repel each other,
due to similar charges on their surfaces (15), such that
K0/[cell] >> 1. Consequently, adhesion can be disrupted
even when p0 is still very small, and a few receptor-ligand
connections persist in binding equilibrium at the interface.
At different values of KD and NL, n can take different values
when half of the virus particles are bound (Fig. 2 C).
Conversely, the number of receptors at which most of the vi-
rus particles are unbound (f ¼ 0.05) differs from the value
below which n% 1 (Fig. 2 B). Our model will thus predict
different and likely more accurate conditions under which
adhesion is abolished than previous models, which consider
that condition to occur when n ¼ 0 (14).
If the affinity between the receptor and the ligand is suf-
ficiently weak, the equilibrium number of connections is
small (i.e., n << min(NR, NL)), and Eq. 9 can be well
approximated by p0 z exp(n). Under such conditions,
the adhesion affinity is (KD,ad)
1 f exp(n) z 1 þ n z n,
thus approximately agreeing with a previous suggestion
that took adhesion affinity to be proportional to n (16). At
moderate receptor-ligand affinities, however, p0, and thus
the adhesion affinity, cannot be estimated from n alone
(Fig. 2 D).Adhesion of influenza virus
We now apply our model to the analysis of the binding of
influenza virus. The influenza virus uses its surface glyco-
protein HA to bind to terminal SA moieties of carbohydrate
chains on the host-cell surface. SA is frequently referred to
as the receptor, and HA as the ligand. HA of avian influenza
(bird flu) strains preferentially binds to SA that is in a2,3
linkage to its neighboring sugar (galactose) in carbohydrate
chains (characteristic of cells in the avian enteric tracts),
whereas HA of influenza strains transmissible in mammals,
including humans, needs to bind to SA in a2,6 linkage to
galactose (characteristic of human trachea airway epithelia)
(28,29). Mutations in the HA sequence can cause a change
in its binding preference from a2,3 linkage to a2,6 linkage,
enabling transmissibility of the virus from birds to mammals
(30), as was demonstrated in highly pathogenic H5N1 influ-
enza strains (37,38).
Adhesion to SA-conjugated biosensors
We will first use our model to analyze the adhesion of influ-
enza virus to SA-conjugated biosensors. This simplified
experimental system, which measures the binding of free vi-Biophysical Journal 110(1) 218–233rus to immobilized SA, has been used to give insights rele-
vant to the attachment of influenza virus to vertebrate cells
and, in particular, to help address the question of the species
specificity of different viral strains.
Recently, Xiong et al. (19) measured the binding affinities
between HA in various influenza strains and SA with a2,3
and a2,6 linkages. The authors also measured the adhesion
affinities of the whole viruses of these strains (except for a
ferret-transmissible mutant of an H5N1 virus) to SA
attached to biosensors, and they demonstrated that a modest
change in the receptor-ligand binding affinity is magnified
to a much larger change in the viral adhesion to the cell sur-
face. Using the empirical model KD,ad ¼ (KD)m, where the
value of m depends on the SA concentration, and where
its value at each SA concentration is estimated from
ln(KD,ad)/ln(KD) using data at multiple HA concentrations,
the authors predicted the binding isotherms of the ferret
transmissible mutant virus and suggested that the small
changes in the HA-SA binding affinities were sufficient to
switch the binding preference of the virus from avian recep-
tors to human receptors.
We analyzed the adhesion measurements by Xiong et al.
(19) using Eq. 1. To validate our model, we fit the two pa-
rameters, K0 and Veff, to three of the measured adhesion iso-
therms and used the parameters to predict the remaining
three measured isotherms. These isotherms relate the
amount of attached viral particles and the relative sugar
loading (i.e., the amount of SA as a fraction of the amount
at maximum loading) on the surface. The fractional satura-
tion of the biosensor by the virus is given by
f ¼ 1
1þ KD;ad=½virus; (20)
where [virus] ¼ 107 mM is the solution concentration of
the virus used in the experiment, and KD,ad varies according
to Eq. 1 with respect to the relative sugar loading. The
values of the fitted parameters are summarized in Table 1,
and the resulting adhesion isotherms are shown in
Fig. 3 A. To compare our model to the empirical model
KD,ad ¼ (KD)m, which is used by Xiong et al. (19) in their
analysis of the data, we computed the multiplicity m ¼
lnKD,ad/lnKD at different relative sugar loading values for
each HA-SA pair, using the KD,ad value estimated from
the experiment (by Eq. 19) and from our model (by
Eq. 1). The results are shown in Fig. 3 B. As expected, the
multiplicity varies with both the relative sugar loading and
the individual KD; this variation is reasonably well captured
by our model.
The KD values of HA-SA binding, used in the fitting and
prediction, are taken from the MST measurements by Xiong
et al. (19) and are listed in Table 2. To further assess the
quality of our model, we took the K0 and Veff values from
the fitting and refit the dissociation constant, KD, of each in-
dividual HA-SA binding to the corresponding adhesion
TABLE 1 Values of the model parameters for influenza virus-
host cell adhesion
NHA NSA K0 (mM) Veff (mM
1)
3  50 2000 1.0 5 0.5  105 2.75 0.3  103
The parameters K0 and Veff are fitted to three experimentally measured iso-
therms. NHA is the number of HA monomers, and NSA is the number of SA
receptors at maximum sugar loading. The number of ligands in our model is
then NL ¼ NHA, and the number of receptors NR ¼ NSA  relative sugar
loading. In principle, NHA and NSA can be treated as fitting parameters as
well. The fitting problem then becomes underrestrained, however, given
the small amount of isotherm data, and there are large statistical uncer-
tainties in the fitted NHA, NSA, and K0 parameters. Instead, we used rough
estimates of NHA and NSA from previous publications. It has been estimated
(19) that 50 HA trimers per virus participate in forming adhesive connec-
tions, and thus NHA z 3  50. The estimate for NSA ranges from 600 to
4500 (19,32,39). We used an intermediate value. Different values of NSA
used in fitting result in compensatory values of Veff, but the consequent iso-
therms are little changed. More accurate measurements of NHA and NSA can
help determine more reliably the parameters K0 and Veff. We have also fit
the parameters K0 and Veff using the exact solution (Eqs. 3 and 4), obtaining
the same values.
Multivalent Adhesion of Influenza 225isotherm (Fig. 3 C). The KD values obtained from the adhe-
sion isotherms are in good agreement with the values deter-
mined from MST (Table 2). This suggests that our model
may be used to estimate the binding affinities from adhesion
experiments. Such an approach may be advantageous when
the adhesion affinity is easier to measure than the receptor-
ligand binding affinity (e.g., when the receptor-ligand bind-
ing is too weak to be detected by the binding assays).
We can check that the fitted value of K0 is reasonable by
using Eq. 14. Assuming that 10% of the virus surface is in
contact with the cell surface (19) (i.e., NHA/MHA z 0.1),
we can estimate the fraction of the SA molecules per adhe-
sion site that lie within contact interface to be NSA/MSA ¼
K0 Veff MHA/NHA z 0.3, a reasonable estimate for the SA-
loaded surfaces considered in this work, which are relatively
flat compared to the virus—more of the available SA mole-
cules per site of adhesion on the cell thus lie within the
interface.Adhesion to cells
Our model can be used to analyze the implications of multi-
valent adhesion in the biological function of influenza virus
and the competitive inhibition of influenza adhesion needed
to effectively reduce influenza infection. Unlike biosensors,
which are conjugated with a pure form of SA-terminated
oligosaccharide, a real vertebrate cell presents a diverse
set of SA-terminated glycans with different affinities for
HA molecules. To characterize the adhesion of influenza vi-
rus to real cells, we ideally need the distribution of binding
affinities, N(K), of the surface glycans to the HA molecules
as input for the model. We also ideally need to fit the values
of K0 and Veff to a series of measured adhesion affinities be-
tween the cells and the influenza virus. The necessary exper-
imental data are not available, however, and so we makesome reasonable assumptions and approximations to enable
us to apply our model to cell-influenza adhesion. Although
some quantitative predictions of our model will improve as
new experimental data yield more realistic parameters,
some of the predictions will remain essentially unchanged
with respect to changes in experimental inputs.
In the following examples, our model is applied to deter-
mine the condition at which adhesion is dramatically altered
(e.g., the value of KD above which the adhesion is effectively
abolished). Here, we discuss why such a condition is insen-
sitive to the value of K0, which may be different between
adhesion to cells and adhesion to biosensors because of
the difference in the nonspecific interactions of the different
adhesion surfaces. According to Eq. 19, the population of
bound virus changes rapidly around KD,adz [cell]. The pre-
dicted parameter q—which may be KD, NR, NL, or the
concentration of hemagglutinin inhibitor (see below)—
corresponding to this condition thus changes with K0 as
dq/dlnK0 ¼ (dlnKD,ad/dq)1. In our model, because
dlnKD,ad/dq is large (e.g., a small change in KD can lead to
orders-of-magnitude change in KD,ad, as discussed below),
dq/dlnK0 is small. This insensitivity to the value of K0 will
be demonstrated in the later discussion on the viable range
of HA-SA binding. We will thus continue to use its value
determined above from the biosensor experiments.
The parameter Veff appears as a scaling factor of KD, ad-
justing the affinity for the confined geometry in which re-
ceptor binding takes place. As such, the predictions of our
model would remain valid, and the adhesion curves would
look identical, for a different value of V
0
eff, if we simply
replace the binding affinity KD with K
0
D ¼ KDVeff/V0eff.
The value of Veff in Table 1 will be used in the subsequent
discussions, but it will be straightforward to update the con-
clusions should new experimental measurements on cell-to-
influenza virus adhesion permit the determination of a more
accurate value of Veff for cells.
Experimental data for the distribution of binding affinity
N(K) is not yet available. Wewill first apply our model using
the assumption that all SA molecules on a cell bind to the
HA molecule with the same binding affinity; later, we
examine the sensitivity of the results to changes in the dis-
tribution of binding affinity.
Multivalency amplifies the weak binding between HA
and SA to achieve strong affinity between the influenza vi-
rus and the host cell. Assuming that the host cells are closely
packed against one another, with an individual diameter of
20 mm, the cell density is then approximately [cell] ¼ 4 
1010 mM. We can estimate the fraction of virus particles
that are bound to the host cells using Eq. 19. The red curve
in Fig. 4 shows how the fraction of virus particles bound to
host cells changes with HA-SA binding affinity. Even when
the affinity is as weak as KD ¼ KD,maxz 10 mM (KD,max is
determined by solving for KD in Eq. 19 with f ¼ 0.5), the
majority of virus particles are still bound to host cells.
The fraction of bound virus particles increases steeplyBiophysical Journal 110(1) 218–233
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FIGURE 3 The agreement between our model and experimental measurements of adhesion. (A) Isotherms of adhesion between influenza virus and bio-
sensors loaded with SA. (Lines) Isotherms predicted by our model; (circles) experimental results. Different colors correspond to different combinations of
viral strains and a2,3-SA or a2,6-SA. (Dashed lines and open circles) The three isotherms used for fitting the model parameters; (solid lines) predictions of
isotherms for which experimental measurements are available. (B) Multiplicity of adhesion, m ¼ lnKD,ad/lnKD, as a function of the relative sugar loading for
different HA-SA pairs. The variation of m across different relative sugar-loading values is reasonably well captured by our model. (C) Computed and
measured isotherms of adhesion, with KD values refitted to each individual isotherm, using the parameter values of K0 and Veff in Table 1. The fractional
saturation predicted by our model is in good agreement with the experimental measurements, with fitted KD values close to those measured by MST.
X-31, HAM, and wild-type (wt) H5 are different influenza strains, each with a different HA sequence and thus different binding affinities for sialic acids
(19) (Table 2). a2,3-SLN (a2,3-linked sialyl lactosamine), a2,6-SLN (a2,6-linked sialyl lactosamine), and a2,6-SL (a2,6-linked sialyl lactose) are different
terminal sialic acid moieties.
226 Xu and Shaw(by >100-fold) as KD decreases from 20 to 5 mM, allowing
the virus to gain affinity to and thus to infect new host spe-
cies by small changes in its HA sequence.
A nascent influenza virus emerging from a host cell must
detach itself from that cell to spread the infection to other
cells. To overcome the strong multivalent adhesion, the vi-
rus uses neuraminidase to cleave the SA moieties at the
adhesion interface (26,27), reducing the number of SA mol-TABLE 2 The dissociation constants, KD, of HA-SA binding
for various viral strains and SA
Viral Strain SA KD (mM) (MST) KD (mM) (Refitted)
X-31 a2,6-SLN 2.1 5 0.3 1.855 0.04
X-31 a2,3-SLN 3.2 5 0.6 3.885 0.07
HAM a2,6-SLN 5.9 5 0.7 5.45 0.2
HAM a2,3-SLN 2.9 5 0.3 3.445 0.08
wt H5 a2,6-SLN 17 5 3 345 4
wt H5 a2,3-SLN 1.1 5 0.2 1.205 0.03
wt H5 a2,6-SL 21 5 6 375 6
The last column lists the KD values estimated by refitting them to the virus
adhesion isotherms, using the K0 and Veff parameters shown in Table 1.
Biophysical Journal 110(1) 218–233ecules available and thus the affinity of adhesion. The stron-
ger the binding between HA and SA, the more SA
neuraminidase needs to cleave for effective release of the vi-
rus. We define a quantity R50, which is the factor by which
the population of SA molecules on the surface needs to be
reduced for half of the virus particles to be unbound.
The blue curve in Fig. 4 plots R50 against KD. At KD ¼
KD,min z 0.08 mM, R50 ¼ 0.01 (KD,min is determined
by solving for KD in Eq. 19 with f ¼ 0.5 and NR ¼
R50 NSA ¼ 0.01 NSA), which implies that neuraminidase
will need to remove 99% of all SA moieties to release
half of the virus particles from the host cell. The enzymatic
efficiency of neuraminidase thus imposes a lower limit of
viable KD in HA-SA binding. On the other hand, the virus
can compensate for inefficient neuraminidase, and develop
resistance to neuraminidase inhibitors (40), with mutations
in HA that decrease HA-SA affinity (41,42).
Our model suggests that KD falls within a range that sat-
isfies the dual requirements that the virus be able to attach to
host cells and, with the aid of neuraminidase, to detach from
them. Values of the parameters—namely the percentage of
FIGURE 4 Dependence of virus adhesion on HA-SA binding affinity.
(Red curve) Fraction of virus particles bound to host cells versus KD of
HA-SA binding. (Dark-blue curve) R50 (see text) versus KD. (Light-green
region) Interval of viable KD values such that the virus can 1) attach suffi-
ciently to and infect cells and 2) release itself, with the help of neuramini-
dase, from the cells to spread the infection. The upper bound of the region
corresponds to the KD value at which half of the viruses attach to cells; the
lower bound corresponds to the KD value at which 99% of all SA moieties
must be removed in order for half of the viruses to detach from the cells.
(Solid curves) Results from Eqs. 1 and 2, which assume that all SA recep-
tors on the cell bind to the HA molecule with the same affinity KD; (dashed
curves) results from Eqs. 16–18, which assume that the binding free energy
is uniformly distributed between RTln(KD/10) and RTln(KD10).
Multivalent Adhesion of Influenza 227SA moieties neuraminidase can remove before the destruc-
tion of the immobilized virus on the cell surface and the
fraction of nascent viral particles that need to detach for suc-
cessful establishment of influenza within a host—are unfor-
tunately not known, but using the speculative values
discussed above yields a permissible range of KD from our
model of KD,min ¼ 0.08 to KD,max ¼ 10 mM. This estimated
range is in line with what has been measured experimentally
(12,19). The specific range estimate can vary depending on
the assumed values of the parameters in our model. This
dependence on the parameters—including the discrete NR
and NL—is easy to analyze: differentiating Eq. 19 using
the chain rule, then substituting the numerical values of
the current parameters, we obtain
d ln kD;min ¼ 1:0 d ln NHA þ 1:2 d ln NSA  d ln Veff
 0:12 d ln K0 þ 0:12 d ln½cell (21)
andd ln kD;max ¼ 1:0 d ln NHA þ 1:0 d ln NSA  d ln Veff
 0:10 d ln K0 þ 0:10 d ln½cell; (22)
which suggest that our estimated range of viable KD has
relative errors comparable to those in the estimates of NHA
and NSA, but is insensitive to the parameters K0 and [cell].
Increasing K0 by a factor of 1000, for example, changes
the estimated viable range by only a factor of ~2, toKD,min¼
0.04 mM and KD,max ¼ 6 mM. Although the predictedvalues of KD,min and KD,max depend on Veff, the width of
the viable range (i.e., KD,max/KD,min) does not.
Different cells will have different SA densities on their
surfaces, and thus different numbers of receptors at the
interface. The fraction of bound virus particles, however,
changes steeply over a narrow range of NR, and remains
essentially constant at ~0 for NR below this range and
at ~1 for NR above this range (Fig. 2 A). This allows us to
divide the cells into two populations, one with an NR above
the midpoint of the transition range and the other with an NR
below it, and to consider only the adhesion of virus to the
first population. The adhesion can thus be analyzed using
a cell concentration adjusted by the fraction of the first pop-
ulation. As shown above in Eqs. 21 and 22, the predictions
of our model are insensitive to the value of [cell], suggesting
that the predictions of our model will remain mostly valid
despite the variability in SA densities among different cells.
We present in the Supporting Material a detailed analysis of
viral adhesion to a population of cells with varying numbers
of interface receptors; KD,max obtained from this analysis is
essentially the same as that calculated for adhesion to cells
with a uniform number of interface receptors.
The above analysis assumes that all SA molecules on the
cell surface bind to the HA molecule with the same binding
affinity KD. On the surface of a real cell, SA moieties in
different glycans may bind to HA with different affinities
KD. We now discuss the effect of such heterogeneity.
We examine a simple, concrete example, in which the
HA-SA binding affinity spans two orders of magnitude
from Kmin to Kmax ¼ 100 Kmin, the binding free energy is
uniformly distributed from RTlnKmin to RTlnKmax, and the
total number of SA molecules is NSA. The distribution is
then N(K) ¼ NSA(ln(Kmax/Kmin))1 K1. Defining the
mean affinity K
0
D h
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
KminKmax
p
, the value of K
0
D then
determines the distribution N(K) (e.g., K
0
D ¼ 1 mM
signifies that the binding affinity ranges from Kmin ¼
0.1 mM to Kmax¼ 10 mM, with the binding free energy uni-
formly distributed in the corresponding range). We can
compute the fraction of bound viral particles and the R50
parameter at different values of K
0
D (the dashed blue and
red curves, respectively, in Fig. 4). Compared to the case
of homogeneous receptors, the viable range of the mean af-
finity is shifted by a factor of ~2, but the width of the range is
similar (K
0
D,max/K
0
D,min ¼ 137 versus KD,max/KD,min ¼ 129).
It will be straightforward to incorporate more realistic esti-
mates of N(K) in our model as innovative experimental
techniques, such as glycan microarrays (43), more compre-
hensively characterize the HA-binding properties of diverse
glycans on real cells.
HAof avian influenza preferentially binds SAofa2,3 link-
age, whereas HA of human influenza preferentially binds
SA of a2,6 linkage. Due to multivalency in the adhesion, a
small difference in the binding affinity can be amplified to
a big difference in biological adhesion. The X-31 HA (an
extensively studied HA construct), for instance, bindsBiophysical Journal 110(1) 218–233
228 Xu and Shawa2,6 SAwith KD¼ 2.15 0.3 mM, and it binds a2,3 SAwith
KD ¼ 3.25 0.6 mM (13). The ability of the whole virus to
adhere to cells, in contrast, can differ drastically between
cells with surface SA of a2,3 linkage and those of a2,6 link-
age: Assuming the parameters in Table 1, the ratio of the
adhesion constants is K
ða2;3Þ
D;ad =K
ða2;6Þ
D;ad ¼ 106 5 3. As another
example, the wild-type HA of the avian strain A/Vietnam/
1194/2004 binds a2,6 SA with KD ¼ 17 5 3 mM (19). A
mutant HA was identified in a strain derived from A/Viet-
nam/1194/2004 that is transmissible in ferrets. This mutant
HA, which contains a handful of point mutations, binds
a2,6 SA with KD ¼ 12 5 2.5 mM (19). According to our
model, this 1.4-fold increase in the binding affinity will
lead to a much larger increase in the adhesion affinity, as
K
ðwild-typeÞ
D;ad =K
ðmutantÞ
D;ad ¼ 101.1 5 0.9, and thus potentially a
much higher fraction of virus particles bound to the mamma-
lian cells. Our model thus quantitatively predicts that
small changes in the HA-SA binding affinities might be
sufficient to switch the binding preference of the virus from
avian cells to human cells, and that a small gain in the hem-
agglutinin’s affinity for human receptors may sufficiently in-
crease the virus’s adhesion to human cells to enable human
infection.
There has been a longstanding interest in developing HA
inhibitors as potential therapeutic agents against influenza
(31,44,45). A competitive inhibitor I of HA forms com-
plexes HAI in the reaction
HAþ I#
KI
HAI; (23)
where KI ¼ [HA][I]/[HAI] is the equilibrium dissociation
constant, and reduces the number of available HA by the
number of complexes formed, NHAI. The presence of the in-
hibitor can be included in our model through the following
set of simultaneous equations for NHAI and n:
ðNHA  NHAI  nÞðNSA  nÞ
n
¼ KDVeff
ðNHA  NHAI  nÞ
NHAI
¼ KI=½I
(24)
andKD;ad ¼ K0exp
0
BB@NHA ln NHA  NHAI  n
NHA

1þ ½I
KI

þ NSA lnNSA  n
NSA
þ n
1
CCA:
(25)
Solving for NHAI in terms of NHA  n and KI /[I] from the
second line of Eq. 24, and substituting it into Eq. 25, weBiophysical Journal 110(1) 218–233can show that KD,ad has the same expression as in Eq. 1,
but with the value of n determined by Eq. 24.
The above equations can be derived from the partition
function of the system
Z ¼ 1
NHA!NSA!
XNHA
m¼ 0

NHA
m

exp

mDm
RT


XminðNHAm; NSAÞ
n¼ 0

NHA  m
n

NSA
n

exp

nDG
RT

;
(26)
where expððDm=RTÞÞ ¼ ½I=KI is the excess chemical po-
tential of the HA-inhibitor complex. In the above, we assume
that the inhibitor is in excess such that the free inhibitor
concentration [I] does not depend on the number of HA-in-
hibitor complexes formed. The probability of spontaneously
breaking all HA-SA connections (i.e., n ¼ 0) is then
p0 ¼ Z1 1
NHA!NSA!
XNHA
m¼ 0
 
NHA
m
!
exp

mDm
RT

¼ Z1 1
NHA!NSA!
ð1þ ½I=KIÞNHA :
(27)
By replacing Z with the largest term in the summand of
Eq. 26, which corresponds to m ¼ NHAI and n ¼ n in
Eq. 24, and applying the Stirling approximation, we arrive
at Eq. 25. The approximation is quite accurate: the ratio of
the approximate value and the exact value of p0 stays close
to 1 across a large range of inhibitor concentrations (Fig. 1B).
Inhibition of the multivalent adhesion depends on inhibi-
tor concentration in a very different manner than inhibition
of monovalent binding, as shown in Fig. 5, in which the
bound fraction of virus particles, normalized by the
maximum bound fraction (at [I] ¼ 0), is plotted against
the inhibitor concentration [I]/KI. The normalized fraction
of HA bound to SA at different inhibitor concentrations,
which is given by fbound/fmax¼ 1/(1þ [I]/KI), if the inhibitor
binds to HAwith much higher affinity than SA (i.e., KI <<
KD), is also shown to contrast the difference between inhibi-
tion of monovalent binding and of multivalent adhesion.
Whereas the normalized fraction of HA bound with SA de-
creases gradually with increasing [I]/KI, reaching half at
[I] ¼ KI, the normalized fraction of bound virus drops pre-
cipitously at different [I]/KI values, depending on the affin-
ity between HA and SA. In viral strains with high HA-SA
affinity KD ¼ 0.5 mM, adhesion is half-inhibited only
when [I]/KI ¼ 20. On the other hand, once [I]/KI exceeds
that value, the normalized fraction steeply decreases, reach-
ing fbound/fmax ¼ 0.001 at [I]/KI ¼ 66. The inhibitor concen-
trations [I]/KI required to reduce the virus adhesion to given
fbound/fmax values are computed for different HA-SA affin-
ities and shown in Fig. 6.
Our analysis above suggests that inhibitors of multivalent
adhesion should be assessed differently than inhibitors of
FIGURE 5 Inhibition of multivalent adhesion
and of monovalent binding. (Solid lines) The
normalized fractions of bound viruses at different
inhibitor concentrations for viruses of different
HA-SA binding affinities. (Dashed line) Fraction
of HA bound to SA at different inhibitor concentra-
tions.
Multivalent Adhesion of Influenza 229monovalent binding. Consider, for example, the challenges
facing the search for effective HA inhibitors: the receptor-
binding pocket of HA is very shallow, making it difficult
for any small molecule to achieve high-affinity (i.e., nano-
molar) binding. It has been hypothesized that a strong HA
inhibitor is required to counter the strong adhesion due to
multivalency, yet to our knowledge no quantitative estimate
has been made as to the inhibitor potency required for effec-
tive inhibition of adhesion. According to our model, a rela-
tively weak HA inhibitor with good bioavailability can
effectively inhibit virus attachment. At a typical plasma con-
centration of [I] ¼ 10 mM, for example, an inhibitor of sub-
micromolar affinity (KI¼ 0.1 mM) is predicted to reduce the
virus binding by ~3000-fold, even for viral strains with HA
of high SA-binding affinities (KD ~ 0.5 mM).The role of binding cooperativity in multivalent
adhesion
Equation 1 is predicated on the constancy of the affinity of
individual receptor-ligand binding throughout the adhesionFIGURE 6 Inhibitor concentrations required to reduce the virus adhesion
to given normalized fractions for different HA-SA affinities. Even when the
affinity of receptor-ligand binding is high, a moderate inhibitor concentra-
tion relative to the inhibition constant is sufficient to drastically reduce viral
adhesion. (Dashed line) Inhibitor concentration required to reduce the equi-
librium number of connections, n, to <1. The inhibitor concentration
required for n % 1 is greater than that required to reduce the fraction of
bound virus by 1000-fold, which suggests that adhesion can be effectively
inhibited before nz 0.interface. The binding affinity of a receptor-ligand pair,
however, may vary with the position of the receptor-ligand
pair within the interface, and it may also be affected by ex-
isting receptor-ligand connections. The latter dependence is
often referred to as cooperativity. Here we discuss the impli-
cations of cooperativity and position-dependent affinity in
multivalent adhesion.
In general, the free energy change of forming n labeled
and distinguishable receptor-ligand connections can be
written as
exp

 GðnÞ
RT

¼
Z Yn
i¼ 1
driexpð  gðr1; r2;/; rnÞ=RTÞ;
(28)
where ri is the position of the ith receptor-ligand pair, and
g(r1,r2,$$$,rn) is the free energy change of forming n con-
nections in the corresponding positions. (We note that
because Eq. 28 refers to distinguishable receptor-ligand
connections, there is no factor of 1/n! on the right-hand
side.) Without better experimental and theoretical character-
ization of the microscopic details of the adhesion interface,
the function G(n) is not known for realistic biological adhe-
sion interfaces, and it is necessary to make some approxima-
tions in our analysis.
The study of adhesion is most often concerned with
the conditions under which adhesion is established or abol-
ished, corresponding to conditions where the bound fraction
is fz 0.5. We will show that the effect of cooperativity on
such conditions diminishes as the numbers of receptors and
ligands at the adhesion interface become large. Under such
conditions, the probability, p0, of spontaneously breaking all
receptor-ligand connections cannot be vanishingly small,
and, according to the above analysis, the equilibrium num-
ber of connections n must be small (Fig. 2). If NR and NL
are large, n << min(NR, NL), the small number of formed
receptor-ligand pairs will almost never be close to each
other, and thus the binding affinity of one pair will not be
affected by other pairs. In such cases, we can ignore the
multibody terms in g, and approximate it asBiophysical Journal 110(1) 218–233
230 Xu and Shawgðr1; r2;/; rnÞz
Xn
i¼ 1
g1ðriÞ (29)
andGðnÞz nRT ln
Z
dr expð  g1ðrÞ=RTÞhnDG; (30)
where DG ¼ RTln(!drexp(g1(r)/RT)) is a constant. The
details of g1(r) determine Veff, the value of which is obtained
by parameter fitting in our model. Equation 1, and thus all
the quantitative results of our model, remain unchanged
when the receptor-ligand affinity varies with the position
in the adhesion interface.
To quantify the effect of cooperativity, we consider a spe-
cial and commonplace case, which is pertinent to the study
of influenza-cell adhesion: cooperativity within oligomeric
receptors or ligands. The effect of such cooperativity on
the equilibrium number of receptor-ligand connections at
the cell-cell adhesion interface has been previously investi-
gated (18); here we study its effect on adhesion affinity. HA
is a homotrimer. Each monomer can individually bind an SA
molecule, and its affinity may depend on the number of SA
molecules already bound to the same HA trimer. If the bind-
ing of k ¼ 1,2,3 SA molecules to the same HA trimer corre-
sponds to the free energy change of DGk, the probability of
breaking all connections is given by
ln p0 ¼ NHA3 ln
NHA3  n1  n2  n3
NHA3
þ NSA lnNSA  n
NSA
þ n;
(31)
where nk is the equilibrium number of HA trimers bound to
k¼ 1,2,3 SA molecules, n ¼ n1 þ 2n2 þ 3n3 is the equi-
librium number of SA molecules bound to HA, and
NHA3 ¼ NHA/3 is the total number of HA trimers. The values
of nk¼1;2;3 are given by the following equilibrium condition:
3ðNHA3  n1  n2  n3ÞðNSA  nÞ
n1
¼ exp

DG1
RT

3ðNHA3  n1  n2  n3ÞðNSA  nÞ2
n2
¼ exp

DG2
RT

ðNHA3  n1  n2  n3ÞðNSA  nÞ3
n3
¼ exp

DG3
RT

n ¼ n1 þ 2n2 þ 3n3:
(32)
Equations 31 and 32, derived in the Supporting Material, ac-
count for the cooperativity in the binding of SAmolecules to
different monomers within a HA trimer. In the absence of
cooperativity, DG3/3 ¼ DG2/2 ¼ DG1 ¼ DG, and Eqs. 31
and 32 can be shown to reduce to Eq. 1.
We introduced into our model the cooperativity between
SA molecules binding to the same HA trimer by the coeffi-
cient g, such that the binding affinity of SA to the firstBiophysical Journal 110(1) 218–233HA monomer is KD Veff, but the subsequent binding
affinities to the remaining two HA monomers in the same
trimer are KD Veff g (i.e., expðDG1=RTÞ ¼ KD Veff ;
expððDG2  DG1Þ=ðRTÞÞ ¼ expððDG3  DG2Þ=ðRTÞÞ ¼
KDVeff g). Attempting to derive the parameter g by fitting
the model to the experimental isotherms yields large statis-
tical uncertainty on its value (the standard error for ln g is
600), suggesting that these experimental isotherms do not
provide sufficient information to infer the presence or the
extent of the cooperativity embodied by our model. The
fitted model (parameters given in the caption of Fig. 7 A) ex-
hibits almost identical isotherms, as does the model without
cooperativity (Fig. 7 A).
To explore the extent to which cooperativity can affect the
adhesion isotherms, we computed R50 as a function of g, for
various NHA3 and KD values, holding the other parameters in
our model to the corresponding values in Table 1 (Fig. 7 B).
As expected, the effect of cooperativity diminishes as the
number of HA trimers increases; when NHA3 ¼ 1000, the ef-
fect of cooperativity is negligible. At the assumed value
NHA3 ¼ 50 for the influenza virus, cooperativity has a
noticeable effect: R50 ¼ 0.030 for g ¼ 0.01, R50 ¼ 0.069
for g ¼ 0.1, and R50 ¼ 0.098 for g ¼ 1 (KD ¼ 1 mM).
The adhesion isotherms of the various viral strains are
plotted for g ¼ 0.1 as dash-and-dot lines in Fig. 7 A.
Cooperativity within the trimer can be similarly consid-
ered in the inhibition of adhesion. Denoting mi as the equi-
librium number of HA trimers that have i ¼ 0,1,2,3
inhibitors bound, and nij as the equilibrium number of HA
trimers that have i inhibitors and j SA molecules bound,
the probability of breaking all HA-SA connections is
ln p0zNHA3 ln
m0  n01  n02  n03
NHA3

1þ ½I
KI
3 þ NSA lnNSA  nNSA þ n
(33)
with the following equilibrium condition: 
3
i
!
m0 
X3
j¼ 1n0j
mi 
X3i
j¼ 1nij
¼

KI
½I
i
; i ¼ 1; 2; 3
 
3 i
j
!
mi 
X3i
k¼ 1nik
nij
¼
exp

DGj
RT

ðNSA  nÞj
;
i ¼ 0; 1; 2; 3; j ¼ 1;.; 3 i
m0 þ m1 þ m2 þ m3 ¼ NHA3X3
i¼ 0
X3i
j¼ 1j nij ¼ n:
(34)
The derivation of Eqs. 33 and 34 is outlined in the Support-
ing Material.
A B
C D
FIGURE 7 The effect of binding cooperativity within the same HA trimer on the isotherms and the inhibition of adhesion. (A) Adhesion isotherms for the
viral strains considered in this work. (Solid lines) Model without cooperativity (i.e., g¼ 1), with the fit parameters in Table 1. (Dashed lines) Model refit with
cooperativity, which yielded a value of gwith large statistical uncertainty. The parameters from the refitting are Veff¼ 2.6 103 mM1, K0¼ 1.2 105, and
g ¼ 72. (Dashed lines are barely visible because they are almost on top of the solid lines, which indicates that the variations of the model that do and do not
consider binding cooperativity produce very similar fits to the experiment.) (Dash-and-dot lines) Isotherms generated with the parameters in Table 1, but with
g ¼ 0.1. (B) The dependence of R50 on the cooperativity parameter g. (C) The effect of cooperativity on the inhibition of adhesion. (Solid lines) Inhibition of
adhesion if there is no cooperativity (i.e., g ¼ 1); (dashed lines) inhibition of adhesion if the binding affinities of the second and third SA molecules are 10-
fold stronger than that of the first SAmolecule to the same HA trimer (g¼ 0.1). (D) The dependence of IC50 values ([I]/KI at which the fraction of bound cells
is half that in absence of the inhibitor) on cooperativity. The values of NSA, Veff, and K0 in Table 1 are used for (B)–(D). In (C), the cell concentration is as
estimated in the text ([cell] ¼ 4  1010 mM). (B–D) Effect of cooperativity diminishes with the number of HA trimers.
Multivalent Adhesion of Influenza 231The binding cooperativity shifts the inhibition curve to
higher inhibitor concentrations: given the parameters in
Table 1, with NHA3 ¼ NHA/3 ¼ 50, a typical HA-SA binding
affinity of KD ¼ 1 mM, and a cooperativity coefficient
g ¼ 0.1, the inhibitor concentration necessary to reduce the
adhesion by half is 1.5 times the concentration necessary if
there is no cooperativity (Fig. 7 C). This shift, however, all
but vanishes at large numbers of trimers (Fig. 7, C and D).
In all the discussions above, we have assumed that the HA
inhibitor has the same inhibition constant against HA any-
where in the adhesion interface that it does against HA in
the solution, which is likely a valid assumption for small-
molecule HA inhibitors. If the inhibitor binding to HA is
diminished or enhanced inside the adhesion interface, our
model would underestimate or overestimate, respectively, the
inhibitor concentration required to inhibit virus-cell adhesion.CONCLUSIONS
Multivalent adhesion at biological surfaces often involves a
very large number of simultaneous receptor-ligand connec-tions, commonly on the order of hundreds to thousands. The
adhesion affinity is the result of both receptor-ligand bind-
ing and nonspecific interactions. We have proposed a model
for the adhesion affinity that takes into account both contri-
butions. Our model gives a simple expression for the
adhesion affinity by taking advantage of approximations
appropriate for large numbers of receptors and ligands.
We have shown that these approximations are accurate for
a wide range of parameters common in biological adhesion.
We have applied our model to the analysis of the adhesion
between influenza virus and SA-conjugated biosensors, and
between influenza virus and vertebrate cells. Compared to
experimental measurements, our model has reasonable
quantitative accuracy using just two fitting parameters.
Our model quantifies the high amplification that results
from the high valency characteristic of many examples of
biological adhesion: the high valency not only amplifies
the weak receptor-ligand binding to produce high-affinity
adhesion but also turns gradual changes in the conditions
(e.g., receptor-ligand affinity, the number of receptors or li-
gands, and the concentration of competitive inhibitors) intoBiophysical Journal 110(1) 218–233
232 Xu and Shawabrupt transitions in adhesion. Analysis of the relationship
between adhesion and receptor-ligand affinity in our model
provides quantitative support for the notion that the range of
observed HA-SA affinities is a natural consequence of the
functional requirements for the influenza virus. When used
to study the inhibition of adhesion by competitive inhibitors
of HA, our model suggests that it might be feasible to inhibit
adhesion with a relatively weak (0.1 mM in dissociation
constant) HA inhibitor. Our model may aid the analysis
of experiments and the design of therapeutic strategies
involving cell-cell and cell-virus adhesion in general.SUPPORTING MATERIAL
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